News &amp; Updates

Coadministration of mRNA-1345, a respiratory syncytial virus (RSV) vaccine, with an influenza (flu) or a COVID-19 vaccine in older adults exhibits good tolerability and has an acceptable reactogenicity profile, according to a US study presented at ESCMID Global Congress 2024.

RSV vaccine plus flu or COVID-19 shots safe, feasible in older adults

13 May 2024

High sodium intake increases BP

Individuals with increased sodium intake experience slight elevations in blood pressure (BP), reports a study involving US Hispanic/Latino adults.

High sodium intake increases BP

NEW INSIGHTS IN THE PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE

At the recent joint convention of the Philippine Lipid and Atherosclerosis Society and the Philippine Society of Hypertension, held last February 21st and 22nd, 2024, Dr Deborah Ona and Dr Federick Cheng shared new insights on primary and secondary prevention of cardiovascular diseases.

NEW INSIGHTS IN THE PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE

Real-world data in Japan: 1L/2L palbociclib-ET effective in HR-positive/HER2-negative advanced breast cancer

Palbociclib combined with endocrine therapy (ET) is effective in hormone receptor (HR)–positive, HER2-negative advanced breast cancer (ABC) in both first-line (1L) and second-line (2L) settings in the real world, a multicentre observational study in Japan has shown.

Real-world data in Japan: 1L/2L palbociclib-ET effective in HR-positive/HER2-negative advanced breast cancer

13 May 2024

Breastfeeding duration has no bearing on IBD risk in offspring

The duration of exclusive or any breastfeeding does not appear to influence the risk of inflammatory bowel disease (IBD) in infants, according to a study.

Breastfeeding duration has no bearing on IBD risk in offspring

Aztreonam-avibactam cracks into hard-to-treat MBL-producing MDR-GNB

The fixed-dose combination of aztreonam and avibactam yields a 41.7-percent clinical cure rate in serious infections caused by metallo-β-lactamase (MBL)–producing multidrug-resistant (MDR) Gram-negative bacteria (GNB), according to the results from the phase III ASSEMBLE trial.

Aztreonam-avibactam cracks into hard-to-treat MBL-producing MDR-GNB

Ceftobiprole as good as daptomycin in achieving S. aureus bloodstream clearance

Ceftobiprole was as effective as daptomycin in achieving bloodstream clearance in patients with complicated Staphylococcus aureus (S. aureus) bacteremia, according to the ERADICATE study presented at ESCMID 2024.

Ceftobiprole as good as daptomycin in achieving S. aureus bloodstream clearance

Antibiotic ‘breathalyzer’ a promising alternative for therapeutic drug monitoring

12 May 2024 by

Analysis of exhaled breath may be able to identify the presence of specific metabolites for four out of five antibiotics, offering a noninvasive approach to performing therapeutic drug monitoring.

Antibiotic ‘breathalyzer’ a promising alternative for therapeutic drug monitoring

Novel connector improves inhaler delivery in ICU

12 May 2024 by

The new inhaler connector RTC 24-V demonstrates fewer medication errors when compared with the 22M-22F, as shown in a study. Healthcare professionals in the intensive care unit (ICU) also prefer it in terms of safety and accuracy.

Novel connector improves inhaler delivery in ICU

Smartphone-based assessment a reliable tool for evaluating frontotemporal lobar degeneration

Remote evaluation of frontotemporal lobar degeneration (FLTD) with the use of smartphones is feasible and reliable and may help with early detection, as reported in a study.

Smartphone-based assessment a reliable tool for evaluating frontotemporal lobar degeneration